InvestorsObserver
×
News Home

Is Acer Therapeutics Inc (ACER) A Winner in the Healthcare Sector?

Wednesday, August 12, 2020 02:36 PM | InvestorsObserver Analysts

Mentioned in this article

Is Acer Therapeutics Inc (ACER) A Winner in the Healthcare Sector?

A rating of 100 puts Acer Therapeutics Inc (ACER) near the top of the Healthcare sector according to InvestorsObserver.

Acer Therapeutics Inc's score of 100 means that it ranks higher than 100% of stocks in the sector. In addition, its overall score of 87 ranks it higher than 87% of all stocks.

Overall Score - 87
ACER has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on ACER!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.

The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Acer Therapeutics Inc Stock Today?

Acer Therapeutics Inc (ACER) stock is trading at $5.06 as of 2:33 PM on Wednesday, Aug 12, a gain of $0.10, or 2.02% from the previous closing price of $4.96. The stock has traded between $4.84 and $5.29 so far today. Volume today is high. So far 733,685 shares have traded compared to average volume of 510,362 shares.

To see InvestorsObserver's Sentiment Score for ACER click here.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App